In contrast, patients with “moderate to high renin” hypertension may display excessive vasoconstriction attributed to renin-angiotensin II activity, thus justifying the prescription of ACEIs/ARBs and β-blockers as preferred treatment options [19]. This evidence concerns the gene AGT and hypertensive disorder.